News | Breast Density | December 02, 2015

Study of 52,962 mammography exams found high breast density not a strong independent risk factor, contrary to recent reports

breast density, mammography, independent risk factor, RSNA 2015

Four different categories of breast density: fatty (top left), scattered fibroglandular (top right), heterogeneously dense (bottom left) and extremely dense (bottom right).


December 2, 2015 — Breast density may not be a strong independent factor for breast cancer risk, according to a new study presented at the annual meeting of the Radiological Society of North America (RSNA).

Prior research has shown an association between breast density and breast cancer. In addition, cancers in dense breast tissue are more difficult to see on mammograms. As a result, some women with dense breasts are advised to get supplementary screening with ultrasound or magnetic resonance imaging (MRI). Some U.S. states have enacted legislation mandating breast density reporting to women undergoing mammography.

"In our study, we found that there was no significant difference in breast density between breast cancer patients and the control group in the screening program," said Natasa Katavic, M.D., from the Department of Radiology at Health Center Osijek in Osijek, Croatia.

For the study, Katavic and colleagues looked at data from 52,962 mammography exams performed in women ages 50 to 69 over five years at five different mammography facilities. Women in Croatia in this age group are invited every two years for mammography by the country's Institute of Public Health.

"We wanted to find out if breast cancer patients had more dense breast tissue than the healthy women," Katavic said. "Also, we wanted to see what the percentage of dense breasts was in our postmenopausal population and, consequently, determine the value of mammography screening for this group."

Two radiologists read the mammograms independently and determined breast density according to standard criteria. The researchers compared data between patients in the low-density breast tissue group and the high-density group.

The majority of screened women had low breast density. Of the 230 detected breast cancers, almost half were from the group with the lowest ranked breast density, while slightly less than 3 percent came from women in the highest breast density category.

When the researchers matched the women who had a detected cancer with control participants of the same age and from the same locales who did not have cancer, they found no significant difference in mammographic density. Women with low mammographic density made up 83 percent of the patients in the breast cancer group, compared with 89 percent in the control group, while high mammographic density was found in 17 percent of the breast cancer patients and 11 percent of women in the control group.

The study did not find a strong association between higher mammographic densities and a higher risk of breast cancer among postmenopausal women, according to Katavic.

"Our study suggests that breast density alone might not be strong independent risk factor for breast cancer," she said. "In risk assessment, all risk factors should be considered before decisions on additional examinations."

The findings also support mammography as an efficient method for early detection of non-palpable breast cancer, Katavic said.

Co-authors on the study are Kristina Bojanic, M.D.; Prof. Kristina Kralik; Tibor Santo, M.D.; Kristina Vidacic, M.D.; Mirta Pacovski, M.D.; and Miroslav Sikora, D.M.D.

For more information: www.radiologyinfo.org


Related Content

News | Magnetic Resonance Imaging (MRI)

Feb. 5, 2026 — Eyas Medical Imaging, Inc. has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its ...

Time February 06, 2026
arrow
News | Ultrasound Women's Health

Feb. 5, 2026 — BrightHeart, a global provider of AI-driven prenatal ultrasound, has announced the availability of its B ...

Time February 05, 2026
arrow
News | Radiation Therapy

Feb. 4, 2026 — On World Cancer Day (02.04.26), the American Society for Radiation Oncology (ASTRO) and the European ...

Time February 04, 2026
arrow
News | Radiology Imaging

Feb. 4, 2026 — The Royal College of Radiologists (RCR) has issued its initial reaction to the British government's ...

Time February 04, 2026
arrow
News | FDA

Feb. 2, 2026 — Imagion Biosystems, Ltd. has submitted an Investigational New Drug (IND) application with the U.S. Food ...

Time February 02, 2026
arrow
News | Breast Imaging | Washington University

Jan. 22, 2026 — In breast cancer, a biopsy is the only diagnostic procedure that can determine if a suspicious lump or ...

Time January 29, 2026
arrow
News | Radiation Oncology

Jan. 27, 2026 — Researchers at the Icahn School of Medicine at Mount Sinai, in collaboration with other leading ...

Time January 29, 2026
arrow
News | Magnetic Resonance Imaging (MRI)

Jan. 27, 2026 — Hyperfine has announced results from the largest data set to date evaluating stroke detection with its ...

Time January 28, 2026
arrow
News | PET Imaging

Jan. 26, 2026 — Nuclidium, a clinical-stage radiopharmaceutical company developing a proprietary copper-based ...

Time January 27, 2026
arrow
News | RSNA

Jan. 22, 2026 — The nomination deadline for the 2026 RSNA Rising Star Award is approaching. The Rising Star Award is ...

Time January 22, 2026
arrow
Subscribe Now